Health equity, SDOH key priorities for ONC, says deputy national coordinator

At the first Friday of the two-day Office of the National Coordinator for Health IT Tech Forum, Deputy National Coordinator Steve Posnack flagged a common theme across the agenda: a focus on social determinants of health, equity and strengthening public health. “These are things that are of immediate interest and have immediate effect in terms… Read More »

FDA Approves Invega Hafyera (paliperidone palmitate) for Twice-Yearly Treatment for Adults with Schizophrenia

[unable to retrieve full-text content]TITUSVILLE, N.J., Sept. 1, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved long-acting atypical antipsychotic Invega Hafyera (6-month paliperidone… Drugs.com – New Drug Approvals

FDA Approves Trudhesa (dihydroergotamine mesylate) Nasal Spray for the Acute Treatment of Migraine

[unable to retrieve full-text content]SEATTLE, Sept. 03, 2021 (GLOBE NEWSWIRE) — Impel NeuroPharma, Inc. (NASDAQ: IMPL), a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial… Drugs.com – New Drug Approvals